141 related articles for article (PubMed ID: 10828032)
1. Expression of c-FLIP(L) and resistance to CD95-mediated apoptosis of monocyte-derived dendritic cells: inhibition by bisindolylmaleimide.
Willems F; Amraoui Z; Vanderheyde N; Verhasselt V; Aksoy E; Scaffidi C; Peter ME; Krammer PH; Goldman M
Blood; 2000 Jun; 95(11):3478-82. PubMed ID: 10828032
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2, Bcl-xL and c-FLIP(L) potentially regulate the susceptibility of human peripheral blood monocyte-derived dendritic cells to cell death at different developmental stages.
Hasebe H; Sato K; Yanagie H; Takeda Y; Nonaka Y; Takahashi TA; Eriguchi M; Nagawa H
Biomed Pharmacother; 2002 May; 56(3):144-51. PubMed ID: 12046686
[TBL] [Abstract][Full Text] [Related]
3. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
Fulda S; Meyer E; Debatin KM
Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
[TBL] [Abstract][Full Text] [Related]
4. Heterogenous susceptibility to CD95-induced apoptosis in melanoma cells correlates with bcl-2 and bcl-x expression and is sensitive to modulation by interferon-gamma.
Ugurel S; Seiter S; Rappl G; Stark A; Tilgen W; Reinhold U
Int J Cancer; 1999 Aug; 82(5):727-36. PubMed ID: 10417772
[TBL] [Abstract][Full Text] [Related]
5. Mature dendritic cells are protected from Fas/CD95-mediated apoptosis by upregulation of Bcl-X(L).
Lundqvist A; Nagata T; Kiessling R; Pisa P
Cancer Immunol Immunother; 2002 May; 51(3):139-44. PubMed ID: 11941452
[TBL] [Abstract][Full Text] [Related]
6. Resistance of short term activated T cells to CD95-mediated apoptosis correlates with de novo protein synthesis of c-FLIPshort.
Schmitz I; Weyd H; Krueger A; Baumann S; Fas SC; Krammer PH; Kirchhoff S
J Immunol; 2004 Feb; 172(4):2194-200. PubMed ID: 14764686
[TBL] [Abstract][Full Text] [Related]
7. Adhesion-mediated intracellular redistribution of c-Fas-associated death domain-like IL-1-converting enzyme-like inhibitory protein-long confers resistance to CD95-induced apoptosis in hematopoietic cancer cell lines.
Shain KH; Landowski TH; Dalton WS
J Immunol; 2002 Mar; 168(5):2544-53. PubMed ID: 11859150
[TBL] [Abstract][Full Text] [Related]
8. IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins.
Conticello C; Pedini F; Zeuner A; Patti M; Zerilli M; Stassi G; Messina A; Peschle C; De Maria R
J Immunol; 2004 May; 172(9):5467-77. PubMed ID: 15100288
[TBL] [Abstract][Full Text] [Related]
9. FLIP is constitutively hyperexpressed in Fas-resistant U266 myeloma cells, but is not induced by IL-6 in Fas-sensitive RPM18226 cells.
Kim DK; Cho ES; Yoo JH; Um HD
Mol Cells; 2000 Oct; 10(5):552-6. PubMed ID: 11101147
[TBL] [Abstract][Full Text] [Related]
10. Enhanced expression of Fas-associated death domain-like IL-1-converting enzyme (FLICE)-inhibitory protein induces resistance to Fas-mediated apoptosis in activated mast cells.
Yoshikawa H; Nakajima Y; Tasaka K
J Immunol; 2000 Dec; 165(11):6262-9. PubMed ID: 11086061
[TBL] [Abstract][Full Text] [Related]
11. Identification of p21 as a target of cycloheximide-mediated facilitation of CD95-mediated apoptosis in human malignant glioma cells.
Glaser T; Wagenknecht B; Weller M
Oncogene; 2001 Aug; 20(35):4757-67. PubMed ID: 11521188
[TBL] [Abstract][Full Text] [Related]
12. TCR-mediated up-regulation of c-FLIPshort correlates with resistance toward CD95-mediated apoptosis by blocking death-inducing signaling complex activity.
Kirchhoff S; Müller WW; Krueger A; Schmitz I; Krammer PH
J Immunol; 2000 Dec; 165(11):6293-300. PubMed ID: 11086065
[TBL] [Abstract][Full Text] [Related]
13. Transition of apoptotic resistant vascular smooth muscle cells to troptotic sensitive state is correlated with downregulation of c-FLIP.
Imanishi T; Hano T; Nishio I; Liles WC; Schwartz SM; Han DK
J Vasc Res; 2000; 37(6):523-31. PubMed ID: 11146406
[TBL] [Abstract][Full Text] [Related]
14. CD95-mediated apoptosis is impaired at receptor level by cellular FLICE-inhibitory protein (long form) in wild-type p53 human ovarian carcinoma.
Mezzanzanica D; Balladore E; Turatti F; Luison E; Alberti P; Bagnoli M; Figini M; Mazzoni A; Raspagliesi F; Oggionni M; Pilotti S; Canevari S
Clin Cancer Res; 2004 Aug; 10(15):5202-14. PubMed ID: 15297424
[TBL] [Abstract][Full Text] [Related]
15. The role of c-FLIP in modulation of CD95-induced apoptosis.
Scaffidi C; Schmitz I; Krammer PH; Peter ME
J Biol Chem; 1999 Jan; 274(3):1541-8. PubMed ID: 9880531
[TBL] [Abstract][Full Text] [Related]
16. HTLV-1 Tax protects against CD95-mediated apoptosis by induction of the cellular FLICE-inhibitory protein (c-FLIP).
Krueger A; Fas SC; Giaisi M; Bleumink M; Merling A; Stumpf C; Baumann S; Holtkotte D; Bosch V; Krammer PH; Li-Weber M
Blood; 2006 May; 107(10):3933-9. PubMed ID: 16403915
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Fas ligand-induced apoptosis by TNF.
Elzey BD; Griffith TS; Herndon JM; Barreiro R; Tschopp J; Ferguson TA
J Immunol; 2001 Sep; 167(6):3049-56. PubMed ID: 11544288
[TBL] [Abstract][Full Text] [Related]
18. Transfection of caspase-3 in the caspase-3-deficient Hodgkin's disease cell line, KMH2, results in enhanced sensitivity to CD95-, TRAIL-, and ARA-C-induced apoptosis.
Wrone-Smith T; Izban KF; Ergin M; Cosar EF; Hsi ED; Alkan S
Exp Hematol; 2001 May; 29(5):572-81. PubMed ID: 11376869
[TBL] [Abstract][Full Text] [Related]
19. CD95/Fas-triggered apoptosis of activated T lymphocytes is prevented by dendritic cells through a CD58-dependent mechanism.
Daniel PT; Scholz C; Essmann F; Westermann J; Pezzutto A; Dörken B
Exp Hematol; 1999 Sep; 27(9):1402-8. PubMed ID: 10480431
[TBL] [Abstract][Full Text] [Related]
20. Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-resistant, long-term activated, antigen-specific T cells.
Strauss G; Knape I; Melzner I; Debatin KM
J Immunol; 2003 Aug; 171(3):1172-82. PubMed ID: 12874203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
